Literature DB >> 2299493

Liver disease in neonatal lupus erythematosus.

R M Laxer1, E A Roberts, K R Gross, J R Britton, E Cutz, J Dimmick, R E Petty, E D Silverman.   

Abstract

We report the cases of neonatal lupus erythematosus associated with significant hepatic involvement in three living infants and in one infant who died 3 hours after delivery. The three living infants had neonatal cholestasis as a major component of their clinical findings. Pathologic changes included giant cell transformation, ductal obstruction, and extramedullary hematopoiesis. Liver involvement has been noted incidentally in children with neonatal lupus erythematosus, but it has generally been attributed to hemodynamic compromise as a result of congenital heart block or systemic toxic reactions. We speculate that neonatal hepatitis proceeding to hepatic fibrosis may occur in neonatal lupus erythematosus, analogous to the occurrence of "idiopathic" congenital heart block. The neonatal hepatitis associated with neonatal lupus erythematosus is a form distinguishable from the "idiopathic" group. Liver involvement may be more common than was previously recognized, and prospective studies to look for maternal autoantibodies in idiopathic neonatal liver disease should be undertaken.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299493     DOI: 10.1016/s0022-3476(05)82880-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population.

Authors:  Christine Capone; Jill P Buyon; Deborah M Friedman; William H Frishman
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

Review 3.  Role of calcium channels in congenital heart block.

Authors:  E Karnabi; M Boutjdir
Journal:  Scand J Immunol       Date:  2010-09       Impact factor: 3.487

4.  Progress in treatment and outcome for children with neonatal haemochromatosis.

Authors:  D M Flynn; N Mohan; P McKiernan; S Beath; J Buckels; D Mayer; D A Kelly
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

Review 5.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 6.  Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.

Authors:  Deborah M Friedman; Ann Rupel; Julie Glickstein; Jill P Buyon
Journal:  Indian J Pediatr       Date:  2002-06       Impact factor: 1.967

Review 7.  Autoantibody-associated congenital heart block: the clinical perspective.

Authors:  Jill P Buyon; Deborah M Friedman
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

8.  Timely referral of infants with jaundice: case report.

Authors:  E A Roberts
Journal:  Can Fam Physician       Date:  1995-12       Impact factor: 3.275

Review 9.  Neonatal lupus: clinical features and management.

Authors:  Lela A Lee
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren's syndrome.

Authors:  Fabiola Reis Oliveira; Valeria Valim; Sandra Gofinet Pasoto; Marilena Leal Mesquita Silvestre Fernandes; Maria Lucia Lemos Lopes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lucia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Libório; Maria Carmen Lopes Ferreira Silva Santos; Leandro Tanure; Juliana DAgostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Samira Tatiyama Miyamoto; Lissiane Karine Noronha Guedes; Alisson Pugliesi; Virginia Fernandes Moça Trevisani
Journal:  Adv Rheumatol       Date:  2021-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.